Navigation Links
New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
Date:5/8/2012

:30 p.m.

(data presented at 2:45 p.m.)

PDT / 5:00 p.m. – 7:30 p.m.

(data presented at 5:45 p.m.) EDTEfficacy of the Tyrosine

Kinase Inhibitor BIBF 1120

in Patients with IPF:

Consistent Pattern of

Primary Endpoint Results

in Sensitivity Analyses of

the TOMORROW trial

L. Richeldi

Oral Presentation

 

Date: Monday, May 21

Time: 2:00 p.m – 4:30 p.m.

(data presented at 2:30 p.m.)

PDT / 5:00 p.m. – 7:30 p.m.

(data presented at 5:30 p.m.) EDTOlodaterolTitleLead Author Presentation details Comparison Of 24-Hour

FEV1 Profile For Once-

Daily Versus Twice-Daily

Treatment With

Olodaterol, A Novel Long-

Acting b2-Agonist, In

Patients With COPD

G. Joos

Thematic Poster # D60

 

Date: Monday, May 21

Time: 10:45 a.m – 12:30 p.m.

PDT / 1:45 p.m. – 3:30 p.m.

EDTLung FunctionTitleLead Author Presentation details Lung Function And

Exercise Impairment In

Patients With GOLD Stage

I And II COPD

D. E. O'Donnell

Thematic Poster  # G74

 

Date: Wednesday, May 23

Time: 8:15 a.m. – 4:30 p.m.

PDT / 11:15 a.m. – 7:30 p.m. EDT

Poster Discussion from

10:45 a.m. – 12:30 p.m. PDT /

1:45 p.m. – 3:30 p.m. EDTBoehringer Ingelheim: Leading respiratory forwardTreatment of respiratory diseases has been a major area of focus for Boehringer Ingelheim for more than 90 years and significant resources are dedicated to research in this field. In addition to new possible treatment options for COPD, Boehringer Ingelheim has also branched out into developing treatment options for other airway diseases, including asthma, lung cancer, idiopathic pulmonary fibrosis and other respiratory diseases.

About Boehringer Ingelheim
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
9. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 MiMedx Group, Inc. (NASDAQ: ... amniotic tissue and patent-protected processes to develop and market ... Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of ... Chief Scientific Officer, will present at the Stem Cell ... Tuesday, October 7, 2014, at 5:00PM Pacific Daylight Time. ...
(Date:9/30/2014)... YORK , Sept. 30, 2014 ... 2014 Summary Global Markets Direct,s, ,Arbor ... provides an overview of the Arbor Pharmaceuticals, LLC.,s ... provides comprehensive information on the current therapeutic developmental ... analysis at various stages, therapeutics assessment by drug ...
(Date:9/30/2014)... Sept. 30, 2014  According to their CEO, ... cancer clinical trials is going through a complete ... the work of the current clinical trial management ... ,next generation, clinical trials, which will ultimately drive ... The company has been recognized by the ...
Breaking Medicine Technology:MiMedx to Present at the Stem Cell Meeting on the Mesa 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 3Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2
... Futuremed Healthcare Products Corporation (" Futuremed ") (TSX: FMD) ... a wholly-owned subsidiary of Cardinal Health, Inc. (NYSE: ... its offer to acquire all of the outstanding common shares ... Common Share in cash (the " Offer ") and mailed ...
... /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ... modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ... Fiscal Year 2012. First quarter ... September 30 , 2011 financial highlights ...
Cached Medicine Technology:Cardinal Health Canada Inc. Mails Offer and Take-Over Bid Circular to Futuremed Shareholders 2Cardinal Health Canada Inc. Mails Offer and Take-Over Bid Circular to Futuremed Shareholders 3Cardinal Health Canada Inc. Mails Offer and Take-Over Bid Circular to Futuremed Shareholders 4TPI Reports First Quarter Fiscal Year 2012 Financial Results 2TPI Reports First Quarter Fiscal Year 2012 Financial Results 3TPI Reports First Quarter Fiscal Year 2012 Financial Results 4TPI Reports First Quarter Fiscal Year 2012 Financial Results 5TPI Reports First Quarter Fiscal Year 2012 Financial Results 6TPI Reports First Quarter Fiscal Year 2012 Financial Results 7TPI Reports First Quarter Fiscal Year 2012 Financial Results 8TPI Reports First Quarter Fiscal Year 2012 Financial Results 9TPI Reports First Quarter Fiscal Year 2012 Financial Results 10TPI Reports First Quarter Fiscal Year 2012 Financial Results 11
(Date:10/1/2014)... Familylifeinsurancequotes.org has released a new blog post explaining ... , Senior citizens can qualify for affordable term life ... who are over 50 years old. Some term life ... examination. , Term life insurance with a simplified issue ... Having life insurance during retirement is important for covering ...
(Date:10/1/2014)... Bedros Keuilian is not only the founder ... camps, he’s also considered the leading expert on marketing ... business summits, a line of high-demand fitness marketing systems ... Spike TV reality show to his name. , With ... for personal trainers and fitness business owners to focus ...
(Date:10/1/2014)... 01, 2014 Phoseon Technology, the pioneer ... to expand the business worldwide. This rapid growth includes ... capacity for manufacturing efforts. The company has experienced average ... years and expects this growth to continue in the ... gains worldwide adoption. , “We are very pleased ...
(Date:10/1/2014)... October 01, 2014 Join the more than ... Disorder Treatment Center’s first ever charity golf tournament to benefit ... with eating disorders who cannot afford treatment. The tournament will ... in Eureka, Mo. , The day-long event starts with ... reception and award dinner will begin at 5 p.m. and ...
(Date:10/1/2014)... Kennebunkport, Maine (PRWEB) October 01, 2014 ... autoimmune disorders in the U.S., according to figures from ... Autoimmune Related Diseases Association (AARDA), and many of them ... higher chance of having undiagnosed celiac disease. Gluten ... helping raise awareness of undiagnosed celiac disease by publishing ...
Breaking Medicine News(10 mins):Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3
... HealthDay Reporter , TUESDAY, Jan. 18 (HealthDay News) ... might have another use: clearing arterial blockages in the ... research involving 19 stroke patients, doctors say this experimental ... patients for whom other clot-removal methods didn,t work. ...
... health may contribute to a healthy respiratory system, according ... . A new study suggests that periodontal disease may ... obstructive pulmonary disease (COPD) and pneumonia. These infections, which ... inhaled into the lower respiratory tract, can be severely ...
... advise about alcohol consumption?" was recently published by Maurizio Ponz ... argues that the message of health benefits of moderate drinking ... the general population." His reasons included (1) many people ... of wine, beer or spirits, and alcohol metabolism may differ ...
... 18 (HealthDay News) -- Women with polycystic ovary syndrome (PCOS) ... many consumer products than other women, a new study suggests. ... products, food and drink packaging and even dental materials. PCOS, ... characterized by excessive production of male sex hormones (androgens). PCOS ...
... XX, 2010) Thea Friedman, M.D., associate scientist and ... Cancer Center at Hackensack University Medical Center was recently ... (NIH-NCI) RO1 research grant to improve allogeneic blood ... grant provides $2 million in funding over the next ...
... is available in French . Montreal, ... in biology at Universit du Qubec Montral (UQAM), supported ... Elsy Edouard, UQAM, Department of Biological Sciences and BIOMED ... B-cell acute lymphocytic leukemia, a disease that occurs most commonly ...
Cached Medicine News:Health News:Stents Show Promise in Treating Brain Blockages 2Health News:Stents Show Promise in Treating Brain Blockages 3Health News:Healthy gums may lead to healthy lungs 2Health News:Critique 029: What should we advise about alcohol consumption? A debate amongst scientists 2Health News:Ovarian Cyst Syndrome May Raise Health Risks from Plastics Chemical 2Health News:Oncology basic research director at John Theurer Cancer Center continues transplantation research 2Health News:Discovery of a gene associated with a leukemia mostly affecting children 2
Rees bayonet forceps, standard, 5-1/2", TC....
... Channel Implants, designed to accept ... surgeon with an excellent reconstructive ... and floor blowout defects. Each ... placement of one or more ...
Medpor Complete Orbit are designed to replace non load bearing bony structures in the orbital area....
... Medpor Inferior Orbital Rim implant can provide ... is designed to be trimmed to meet ... small flange allows it to rest on ... floor. This flange allows easier positioning of ...
Medicine Products: